These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31745354)

  • 1. 'Make Ebola a thing of the past': first vaccine against deadly virus approved.
    Callaway E
    Nature; 2019 Nov; 575(7783):425-426. PubMed ID: 31745354
    [No Abstract]   [Full Text] [Related]  

  • 2. Ebola vaccines for mass immunisation in affected regions.
    Agnandji ST; Loembe MM
    Lancet Infect Dis; 2022 Jan; 22(1):8-10. PubMed ID: 34529960
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid Confirmation of the Zaire Ebola Virus in the Outbreak of the Equateur Province in the Democratic Republic of Congo: Implications for Public Health Interventions.
    Mbala-Kingebeni P; Villabona-Arenas CJ; Vidal N; Likofata J; Nsio-Mbeta J; Makiala-Mandanda S; Mukadi D; Mukadi P; Kumakamba C; Djokolo B; Ayouba A; Delaporte E; Peeters M; Muyembe Tamfum JJ; Ahuka-Mundeke S
    Clin Infect Dis; 2019 Jan; 68(2):330-333. PubMed ID: 29961823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guns N' viruses.
    Häfner S
    Microbes Infect; 2019; 21(3-4):125-128. PubMed ID: 30684684
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ebola : an uncontrolled outbreak despite vaccines and new treatments].
    Vetter P; Kaiser L
    Rev Med Suisse; 2020 Apr; 16(690):739-743. PubMed ID: 32301308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus.
    Mire CE; Matassov D; Geisbert JB; Latham TE; Agans KN; Xu R; Ota-Setlik A; Egan MA; Fenton KA; Clarke DK; Eldridge JH; Geisbert TW
    Nature; 2015 Apr; 520(7549):688-691. PubMed ID: 25853476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to demonstration of Ebola virus vaccine efficacy.
    Krause PR; Cavaleri M; Coleman G; Gruber MF
    Lancet Infect Dis; 2015 Jun; 15(6):627-9. PubMed ID: 26008825
    [No Abstract]   [Full Text] [Related]  

  • 8. Worries about Ebola outbreak grow, despite use of vaccine.
    Cohen J
    Science; 2018 Dec; 362(6420):1225. PubMed ID: 30545864
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlates of vaccine-induced protective immunity against Ebola virus disease.
    Medaglini D; Santoro F; Siegrist CA
    Semin Immunol; 2018 Oct; 39():65-72. PubMed ID: 30041831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early trials of Ebola vaccine show immune response.
    Mayor S
    BMJ; 2015 Apr; 350():h1844. PubMed ID: 25855620
    [No Abstract]   [Full Text] [Related]  

  • 11. Ebola virus - prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine.
    Robinson HL; Marzi A
    Expert Rev Vaccines; 2018 Sep; 17(9):769-771. PubMed ID: 30092691
    [No Abstract]   [Full Text] [Related]  

  • 12. How Ebola-vaccine success could reshape clinical-trial policy.
    Butler D; Callaway E; Check Hayden E
    Nature; 2015 Aug; 524(7563):13-4. PubMed ID: 26245556
    [No Abstract]   [Full Text] [Related]  

  • 13. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 14. DR Congo: investigational research against Ebola virus.
    Green A
    Lancet; 2018 Jun; 391(10137):2308-2309. PubMed ID: 30047403
    [No Abstract]   [Full Text] [Related]  

  • 15. Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of Protection.
    Longet S; Mellors J; Carroll MW; Tipton T
    Front Immunol; 2020; 11():599568. PubMed ID: 33679690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebola in eastern DRC.
    Rollin PE
    Lancet Infect Dis; 2019 Oct; 19(10):1049-1050. PubMed ID: 31402103
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress towards a vaccine against Ebola to meet emergency medical countermeasure needs.
    Wolfe DN; Zarrabian AG; Disbrow GL; Espeland EM
    Vaccine; 2019 Nov; 37(48):7178-7182. PubMed ID: 29199040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plan to use second Ebola vaccine sparks debate.
    Kupferschmidt K
    Science; 2019 Jun; 364(6447):1221. PubMed ID: 31249040
    [No Abstract]   [Full Text] [Related]  

  • 19. The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms.
    O'Donnell K; Marzi A
    Expert Rev Vaccines; 2020 Mar; 19(3):267-277. PubMed ID: 32129120
    [No Abstract]   [Full Text] [Related]  

  • 20. Ebola vaccine success.
    Mullard A
    Nat Rev Drug Discov; 2017 Feb; 16(2):77. PubMed ID: 28148944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.